Vanguard Group Inc Mirum Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,540,061 shares of MIRM stock, worth $134 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,540,061
Previous 2,424,734
4.76%
Holding current value
$134 Million
Previous $100 Million
14.13%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MIRM
# of Institutions
227Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$358 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$251 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$171 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$147 Million5.54% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.53MShares$133 Million2.42% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.94B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...